These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29230671)

  • 41. Immunotherapy for genitourinary malignancies in the here and now!
    Slovin SF
    Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
    [No Abstract]   [Full Text] [Related]  

  • 42. Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy.
    McGregor BA; Sonpavde GP
    Eur Urol Focus; 2020 Jan; 6(1):14-16. PubMed ID: 30910391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methyltransferase inhibitors: an updated patent review (2012-2015).
    Xu P; Hu G; Luo C; Liang Z
    Expert Opin Ther Pat; 2016 Sep; 26(9):1017-30. PubMed ID: 27376512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decitabine--bedside to bench.
    Oki Y; Aoki E; Issa JP
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):140-52. PubMed ID: 17023173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric genitourinary tumors.
    Buckley KS
    Curr Opin Oncol; 2011 May; 23(3):297-302. PubMed ID: 21460723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
    Fandy TE
    Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma.
    Shapiro DD; Harel M; Ferrer F; McKenna PH
    Int Urol Nephrol; 2016 Jul; 48(7):1009-13. PubMed ID: 27068815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene methylation and early detection of genitourinary cancer: the road ahead.
    Cairns P
    Nat Rev Cancer; 2007 Jul; 7(7):531-43. PubMed ID: 17585333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.
    Ehrlich M; Woods CB; Yu MC; Dubeau L; Yang F; Campan M; Weisenberger DJ; Long T; Youn B; Fiala ES; Laird PW
    Oncogene; 2006 Apr; 25(18):2636-45. PubMed ID: 16532039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.
    Lin RK; Hsu HS; Chang JW; Chen CY; Chen JT; Wang YC
    Lung Cancer; 2007 Feb; 55(2):205-13. PubMed ID: 17140695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bibliography. Current world literature. Genitourinary systems.
    Curr Opin Oncol; 2007 May; 19(3):273-91. PubMed ID: 17469214
    [No Abstract]   [Full Text] [Related]  

  • 52. DNA methyltransferases in hematologic malignancies.
    Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
    Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
    Bianconi M; Santoni M; Massari F; Faloppi L; Del Prete M; Giampieri R; Ciccarese C; Modena A; Tortora G; Scartozzi M; Cascinu S
    Future Oncol; 2014 Nov; 10(14):2103-6. PubMed ID: 25471023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors.
    Costa de Padua T; Sabino Marques Monteiro F; Necchi A; Spiess PE
    Eur Urol; 2024 May; 85(5):414-416. PubMed ID: 38403526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational fishing of new DNA methyltransferase inhibitors from natural products.
    Maldonado-Rojas W; Olivero-Verbel J; Marrero-Ponce Y
    J Mol Graph Model; 2015 Jul; 60():43-54. PubMed ID: 26099696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
    Lee MG; Huh JS; Chung SK; Lee JH; Byun DS; Ryu BK; Kang MJ; Chae KS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Oncogene; 2006 Sep; 25(42):5807-22. PubMed ID: 16909101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute depletion redefines the division of labor among DNA methyltransferases in methylating the human genome.
    Tiedemann RL; Putiri EL; Lee JH; Hlady RA; Kashiwagi K; Ordog T; Zhang Z; Liu C; Choi JH; Robertson KD
    Cell Rep; 2014 Nov; 9(4):1554-66. PubMed ID: 25453758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of administrative data for comparative effectiveness research in the treatment of non-prostate genitourinary malignancies.
    Edwards DC; Cahn DB; Smaldone MC; Kutikov A
    Urol Oncol; 2018 Apr; 36(4):193-212. PubMed ID: 28867432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA Methyltransferase Inhibitors: Development and Applications.
    Lopez M; Halby L; Arimondo PB
    Adv Exp Med Biol; 2016; 945():431-473. PubMed ID: 27826847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lead (Pb) exposure reduces global DNA methylation level by non-competitive inhibition and alteration of dnmt expression.
    Sanchez OF; Lee J; Yu King Hing N; Kim SE; Freeman JL; Yuan C
    Metallomics; 2017 Feb; 9(2):149-160. PubMed ID: 27934997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.